ORLANDO
CONFERENCE
November 18, 2023
Sheraton Orlando
Lake Buena Vista Resort
Society Endorsement
About GALA
The primary objective of the GI and Liver Association of the Americas (GALA) is to deliver current and comprehensive education to medical practitioners and healthcare professionals responsible for the well-being of individuals with persistent liver and gastrointestinal conditions.
Benefit from insights shared by international experts and participate in dialogues with peers, exploring the latest advancements in chronic liver and gastrointestinal diseases.
COURSE DIRECTOR
Manuel Amaris, MD
Motility Program Director
Clinical Associate Professor
Gastroenterology, Hepatology, and Nutrition
University of Florida
Gainesville, Florida
FACULTY
Robert S. Brown, Jr., MD, MPH
Weill Cornell Medicine
New York, New York
Jana Al Hashash, MD
Mayo Clinic
Jacksonville, Florida
Paul Martin, MD
University of Miami Miller School of Medicine
Miami, Florida
Siobhan Proksell, MD
University of Miami Miller School of Medicine
Miami, Florida
Carol Burke, MD, FACP, FACG, FASGE, AGAF
Cleveland Clinic
Cleveland, Ohio
Ayman Koteish, MD, FAASLD
AdventHealth Transplant Institute
Orlando, Florida
Lyda Cuervo Pardo, MD
University of Florida
Gainesville, Florida
Lawrence Schiller, MD
Baylor University Medical Center
Dallas, Texas
AGENDA
7:30 AM – 8:30 AM
Breakfast and Registration
8:30 AM – 8:35 AM
Welcome
Session I
8:35 AM – 9:05 AM
Integrated Multidisciplinary Patient-Centered Approach for the Treatment of IBS
Manuel Amaris, MD
9:05 AM – 9:30 AM
Eosinophilic Esophagitis in 2023:
Standard and Emerging Treatments
Lyda Cuervo Pardo, MD
9:30 AM – 10:00 AM
Overcoming Antibiotic Resistance:
New Approaches to H. pylori and C. difficile
Lawrence Schiller, MD
10:00 AM – 10:15 AM
Q&A/Panel Discussion
10:15 AM – 10:30 AM
Break
Session II
10:30 AM – 11:00 AM
Non-alcoholic Fatty Liver Disease (NAFLD):
Changing Nomenclature and Emerging Therapies
Paul Martin, MD
11:00 AM – 11:30 AM
Genetic and Autoimmune Liver Diseases:
Progress in Disease Management
Ayman Koteish, MD
11:30 AM – 12:00 PM
Advanced Cirrhosis: Managing Hepatorenal Syndrome and Hepatic Encephalopathy
Robert Brown, MD
12:00 PM – 12:20 PM
Q&A/Panel Discussion
12:20 PM – 12:50 PM
Break / Lunch
12:50 PM – 1:35 PM
First and Only FDA Approved
Eosinophilic Esophagitis (EoE) Treatment
John Jacobs, MD
Industry Sponsored Event (Non-accredited)
Sponsored By Sanofi / Regeneron
1:35 PM – 2:35 PM
Parallel Sessions
-
GI Woes from Head to Toe
-
Case Studies in Inflammatory Bowel Disease
-
Case Studies in Chronic Liver Disease
2:35 PM – 2:50 PM
Break
SESSION III
2:50 PM – 3:20 PM
Inflammatory Bowel Disease:
Positioning Currently Approved Therapies
Jana Al Hashash, MD
3:20 PM – 4:05 PM
Inflammatory Bowel Disease:
Emerging Therapies in 2024
Siobhan Proksell, MD
4:05 PM – 4:35 PM
Colon Cancer Screening:
Review of Recently Updated Guidelines
Carol Burke, MD
4:35 PM – 4:50 PM
Q&A/Panel Discussion
4:50 PM – 4:55 PM
Meeting Wrap-up
VENUE
Sheraton Orlando Lake Buena Vista Resort
12205 S. Apopka Vineland Road
Orlando, Florida 32836
This activity is supported by educational grants from Aimmune Therapeutics, CymaBay Therapeutics, Inc., Ipsen Biopharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Phathom Pharmaceuticals, Inc, Salix Pharmaceuticals, and Seres Therapeutics.
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas (GALA), and the Texas Liver Institute.
